STREAMEX CORP. (STEX) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-29.96M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.06× | Operating cash flow / net income. Period ending 2026-06-30. $-29.96M ÷ $-500.83M ≈ 0.06× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -29.96M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -500.83M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $-29.96M | (m) | (m) | (m) | (m) | $-500.83M | (m) | (m) | (m) | 0.06× |
| 2026-03-31 | (m) | (m) | $-19.50M | (m) | (m) | (m) | (m) | $-506.66M | (m) | (m) | (m) | 0.04× |
| 2025-12-31 | (m) | (m) | $-10.44M | (m) | (m) | (m) | (m) | $-462.77M | (m) | (m) | (m) | 0.02× |
| 2025-09-30 | (m) | (m) | $-7.89M | (m) | (m) | (m) | (m) | $-39.87M | (m) | (m) | (m) | 0.20× |
| 2025-06-30 | (m) | (m) | $-4.36M | (m) | (m) | (m) | (m) | $-26.20M | (m) | (m) | (m) | 0.17× |
| 2025-03-31 | (m) | (m) | $-4.56M | (m) | (m) | (m) | (m) | $-9.74M | (m) | (m) | (m) | 0.47× |
| 2024-12-31 | (m) | (m) | $-4.76M | (m) | (m) | $40.00K | (m) | $-10.33M | (m) | (m) | (m) | 0.46× |
| 2024-09-30 | (m) | (m) | $-7.23M | (m) | (m) | $39.00K | (m) | $-15.28M | (m) | (m) | (m) | 0.47× |
| 2024-06-30 | (m) | (m) | $-9.56M | (m) | (m) | $40.00K | (m) | $-17.93M | (m) | (m) | (m) | 0.53× |
| 2024-03-31 | (m) | (m) | $-12.98M | (m) | (m) | $27.00K | (m) | $-25.11M | (m) | (m) | (m) | 0.52× |
| 2023-12-31 | $-17.50M | (m) | $-17.31M | $186.00K | (m) | $18.00K | (m) | $-29.04M | (m) | (m) | -97216.67% | 0.60× |
| 2023-09-30 | $-18.73M | (m) | $-18.48M | $240.00K | (m) | $141.00K | (m) | $-29.95M | (m) | (m) | -13280.14% | 0.62× |
| 2023-06-30 | $-19.83M | (m) | $-19.60M | $230.00K | (m) | $275.00K | (m) | $-31.75M | (m) | (m) | -7212.36% | 0.62× |
| 2023-03-31 | (m) | (m) | (m) | $158.00K | (m) | $283.00K | (m) | $-26.42M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-21.87M | (m) | $-21.70M | $168.00K | (m) | $286.00K | (m) | $-27.05M | (m) | (m) | -7647.90% | 0.80× |
| 2022-09-30 | $-23.58M | (m) | $-23.32M | $254.00K | (m) | $159.00K | (m) | $-28.74M | (m) | (m) | -14827.67% | 0.81× |
| 2022-06-30 | $-25.55M | (m) | $-25.13M | $420.00K | (m) | $132.00K | (m) | $-29.62M | (m) | (m) | -19358.33% | 0.85× |
| 2022-03-31 | $-25.82M | (m) | $-25.35M | $467.00K | (m) | $331.00K | (m) | $-31.56M | (m) | (m) | -7799.40% | 0.80× |
| 2022-03-30 | (m) | (m) | $6.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-26.94M | (m) | $-26.40M | $542.00K | (m) | $441.00K | (m) | $-31.92M | (m) | (m) | -6109.07% | 0.83× |
| 2021-09-30 | $-27.20M | (m) | $-26.77M | $425.00K | (m) | (m) | (m) | $-33.56M | (m) | (m) | (m) | 0.80× |
| 2021-06-30 | $-26.53M | (m) | $-26.29M | $241.00K | (m) | (m) | (m) | $-37.71M | (m) | (m) | (m) | 0.70× |
| 2021-03-31 | $-27.85M | (m) | $-27.65M | $197.00K | (m) | (m) | (m) | $-49.20M | (m) | (m) | (m) | 0.56× |
| 2020-12-31 | $-26.69M | (m) | $-26.60M | $87.00K | (m) | (m) | (m) | $-52.22M | (m) | (m) | (m) | 0.51× |
| 2020-09-30 | $-24.55M | (m) | $-24.40M | $153.94K | (m) | (m) | (m) | $-56.74M | (m) | (m) | (m) | 0.43× |
| 2020-06-30 | $-22.22M | (m) | $-22.06M | $159.94K | (m) | (m) | (m) | $-50.78M | (m) | (m) | (m) | 0.43× |
| 2020-03-31 | $-18.09M | (m) | $-17.90M | $183.15K | (m) | (m) | (m) | $-39.54M | (m) | (m) | (m) | 0.45× |
| 2019-12-31 | $-15.66M | (m) | $-15.48M | $177.09K | (m) | (m) | (m) | $-34.08M | (m) | (m) | (m) | 0.45× |
| 2019-09-30 | $-14.65M | (m) | $-14.55M | $99.66K | (m) | (m) | (m) | $-9.58M | (m) | (m) | (m) | 1.52× |
| 2019-06-30 | $-13.18M | (m) | $-13.10M | $75.06K | (m) | (m) | (m) | $-8.05M | (m) | (m) | (m) | 1.63× |
| 2019-03-31 | $-11.44M | (m) | $-11.39M | $48.81K | (m) | (m) | (m) | $-5.87M | (m) | (m) | (m) | 1.94× |
| 2018-12-31 | $-10.29M | (m) | $-10.26M | $38.03K | (m) | (m) | (m) | $-17.25M | (m) | (m) | (m) | 0.59× |
| 2018-09-30 | $-9.57M | (m) | $-9.54M | $24.32K | (m) | (m) | (m) | $-16.10M | (m) | (m) | (m) | 0.59× |
| 2018-06-30 | $-8.83M | (m) | $-8.81M | $16.03K | (m) | (m) | (m) | $-14.75M | (m) | (m) | (m) | 0.60× |
| 2018-03-31 | $-8.26M | (m) | $-8.25M | $11.46K | (m) | (m) | (m) | $-12.06M | (m) | (m) | (m) | 0.68× |
| 2017-12-31 | $-7.48M | (m) | $-7.47M | $9.44K | (m) | (m) | (m) | $-12.70M | (m) | (m) | (m) | 0.59× |
| 2017-09-30 | $-6.49M | (m) | $-6.48M | $10.95K | (m) | (m) | (m) | $-9.53M | (m) | (m) | (m) | 0.68× |
| 2017-06-30 | $-5.81M | (m) | $-5.79M | $12.32K | (m) | (m) | (m) | $-9.26M | (m) | (m) | (m) | 0.63× |
| 2017-03-31 | $-5.57M | (m) | $-5.55M | $17.88K | (m) | (m) | (m) | $-12.28M | (m) | (m) | (m) | 0.45× |
| 2016-12-31 | $-5.12M | (m) | $-5.11M | $16.25K | (m) | (m) | (m) | $-11.59M | (m) | (m) | (m) | 0.44× |
| 2016-09-30 | $-4.96M | (m) | $-4.94M | $18.99K | (m) | (m) | (m) | $-12.24M | (m) | (m) | (m) | 0.40× |
| 2016-06-30 | $-4.73M | (m) | $-4.72M | $12.45K | (m) | (m) | (m) | $-10.32M | (m) | (m) | (m) | 0.46× |
| 2016-03-31 | $-4.48M | (m) | $-4.47M | $13.18K | (m) | (m) | (m) | $-8.99M | (m) | (m) | (m) | 0.50× |
| 2015-12-31 | $-4.54M | (m) | $-4.52M | $15.86K | (m) | (m) | (m) | $-9.46M | (m) | (m) | (m) | 0.48× |
| 2015-09-30 | $-3.90M | (m) | $-3.89M | $8.97K | (m) | (m) | (m) | $-10.04M | (m) | (m) | (m) | 0.39× |
| 2015-06-30 | $-3.62M | (m) | $-3.60M | $12.93K | (m) | (m) | (m) | $-14.38M | (m) | (m) | (m) | 0.25× |
| 2015-03-31 | $-2.72M | (m) | $-2.71M | $6.65K | (m) | (m) | (m) | $-10.41M | (m) | (m) | (m) | 0.26× |
| 2014-12-31 | $-2.00M | (m) | $-2.00M | $3.96K | (m) | (m) | (m) | $-8.47M | (m) | (m) | (m) | 0.24× |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-1.77M | (m) | $-1.76M | $11.72K | (m) | (m) | (m) | $-9.80M | (m) | (m) | (m) | 0.18× |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |